GAITHERSBURG, Md.--(BUSINESS WIRE)--MaxCyte, Inc., the pioneer in scalable, high performance cell loading systems, announces that there will be a presentation on the MaxCyte® STX™ Scalable Transfection System on Friday, February 27, at the Drug Discovery for Ion Channels Satellite Meeting of the Biophysical Society 53rd Annual Meeting. The title of the presentation is “Expression of Membrane Proteins in Primary Cells and Cell Lines Using a Large Scale Electroporation-Based Transient Transfection Technology.” Authors of the presentation are Dr. Linhong Li, Senior Scientist, and Dr. James Brady, Director of Technical Applications at MaxCyte.
